Recruiting
Phase 3

Pelacarsen

Sponsor:

Novartis Pharmaceuticals

Code:

NCT06267560

Conditions

Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

TQJ230

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information